These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15604066

  • 1. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
    Wan X, Huang HH, Li JG.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1391-4. PubMed ID: 15604066
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
    [Abstract] [Full Text] [Related]

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 4. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
    Wu W, Ding HL, Chen LH, Fu ZZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec 20; 26(12):1742-4. PubMed ID: 17259110
    [Abstract] [Full Text] [Related]

  • 5. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1288-93. PubMed ID: 15387968
    [Abstract] [Full Text] [Related]

  • 6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 7. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats].
    Duan HJ, Liu SX, Zhang YJ, Liu QJ, He N, Li YM.
    Yao Xue Xue Bao; 2004 Jul 02; 39(7):481-5. PubMed ID: 15493832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 02; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 11. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy].
    Xu JY, Tao LJ, Wang L, Ning WB, Liu JS.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 02; 33(9):836-40. PubMed ID: 18812664
    [Abstract] [Full Text] [Related]

  • 12. [Effects of captopril and losartan on expression of kidney aquaporin-2 mRNA and urine aquaporin-2 excretion in rats].
    Jiang RY, Xu DL, Lai WY, Ren H, Shen QB, Shao YH.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr 02; 25(4):391-4. PubMed ID: 15837635
    [Abstract] [Full Text] [Related]

  • 13. Losartan inhibited expression of matrix metalloproteinases in rat atherosclerotic lesions and angiotensin II-stimulated macrophages.
    Liang C, Wu ZG, Ding J, Jiang JF, Huang GZ, Du RZ, Ge JB.
    Acta Pharmacol Sin; 2004 Nov 02; 25(11):1426-32. PubMed ID: 15525463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of losartan on expressions of plasminogen activator and plasminogen activator inhibitor-1 of rat proximal tubular epithelial cells cultured with high glucose].
    Pu LJ, Huang SM, Liu F.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep 02; 38(5):813-5. PubMed ID: 17953365
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
    Yao XM, Ye SD, Chen Y, Zai ZM, Li XC, Wang YX, Chen K.
    Diabetes Obes Metab; 2009 May 02; 11(5):519-22. PubMed ID: 19236438
    [Abstract] [Full Text] [Related]

  • 18. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 May 02; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 19. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
    Dong FQ, Li H, Cai WM, Tao J, Li Q, Ruan Y, Zheng FP, Zhang Z.
    Chin Med J (Engl); 2004 Jul 02; 117(7):1040-4. PubMed ID: 15265379
    [Abstract] [Full Text] [Related]

  • 20. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z, Huang C, Liang C, Chen B, Chen S, Sun W.
    Cell Mol Immunol; 2005 Apr 02; 2(2):150-4. PubMed ID: 16191423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.